Original Research

Accepted on 26 Apr 2024

Effectiveness of Different Booster Vaccine Combinations Against SARS-CoV-2 During a Six-Month Follow-Up in Mexico and Argentina

in Vaccines and Molecular Therapeutics

Arnulfo Garza-Silva
Diego Rivera-Silva
Andrea Rivera-Cavazos
Iván Francisco Fernández-Chau
Andrea Belinda Cepeda-Medina
Devany Paola Morales-Rodríguez
Irene Antonieta Barco-Flores
Miguel Ángel Sanz-Sánchez
Cecilia Acciardi
Graciela Paez-Bo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1403784

Original Research

Accepted on 26 Apr 2024

Tissue-specific sex differences in pediatric and adult immune cell composition and function

in Vaccines and Molecular Therapeutics

Mahina Tabassum Mitul
Jenna Kastenschmidt
Suhas Sureshchandra
Zachary W Wagoner
Andrew M Sorn
David Robert McIlwain
Jenny E Hernandez-Davies
Aarti Jain
RAFAEL ASSIS
Douglas Trask

Frontiers in Immunology

doi 10.3389/fimmu.2024.1373537

Original Research

Accepted on 25 Apr 2024

Sex Differences in Immune Protection in Mice Conferred by Heterologous Vaccines for Pneumonic Plague

in Vaccines and Molecular Therapeutics

Michael Davies
Sergei S Biryukov
Nathaniel O Rill
Christopher P Klimko
Melissa Hunter
Jennifer Dankmeyer
Jeremy A Miller
Jennifer L Shoe
Kevin Mlynek
Yuli Talyansky

Frontiers in Immunology

doi 10.3389/fimmu.2024.1397579

Original Research

Accepted on 24 Apr 2024

Vaccine hesitancy in patients presenting to a specialized allergy center: clinical relevant sensitizations, impact on mental health and vaccination rates

in Vaccines and Molecular Therapeutics

Natalie Kogseder
Viktoria Puxkandl
Wolfram Hoetzenecker
Sabine Altrichter

Frontiers in Immunology

doi 10.3389/fimmu.2024.1324987

Original Research

Accepted on 24 Apr 2024

Low-dose M.tb infection but not BCG or MTBVAC vaccination enhances heterologous antibody titers in non-human primates

in Vaccines and Molecular Therapeutics

Marco Polo Peralta Alvarez
Holly Jones
Hugo Redondo Azema
Chloe Davis
Andrew D White
Charlotte Sarfas
Mike Dennis
Shuailin Li
Daniel Wright
Eugenia Puentes

Frontiers in Immunology

doi 10.3389/fimmu.2024.1387454

Original Research

Published on 24 Apr 2024

A conserved motif in the immune-subdominant RAP-1 related antigen of Babesia bovis contains a B-cell epitope recognized by antibodies from protected cattle

in Vaccines and Molecular Therapeutics

Manuel J. Rojas
Reginaldo G. Bastos
Jinna Navas
Jacob M. Laughery
Paul A. Lacy
Carlos E. Suarez

Frontiers in Immunology

doi 10.3389/fimmu.2024.1380660

181 views

Methods

Published on 24 Apr 2024

Refined analytical pipeline for the pharmacodynamic assessment of T-cell responses to vaccine antigens

in Vaccines and Molecular Therapeutics

Michail Angelos Pavlidis
Nadia Viborg
Mads Lausen
Birgitte Rønø
Daniela Kleine-Kohlbrecher

Frontiers in Immunology

doi 10.3389/fimmu.2024.1404121

254 views

Mini Review

Published on 23 Apr 2024

Maintenance of homeostasis by TLR4 ligands

in Vaccines and Molecular Therapeutics

Masataka Oda
Hirofumi Yamamoto
Takashige Kawakami

Frontiers in Immunology

doi 10.3389/fimmu.2024.1286270

150 views

Original Research

Accepted on 22 Apr 2024

Long-term humoral and cellular immunity against vaccine strains and Omicron subvariants (BQ.1.1, BN.1, XBB.1, and EG.5) after bivalent COVID-19 vaccination

in Vaccines and Molecular Therapeutics

Hakjun Hyun
Eliel Nham
Hye Seong
Jin Gu Yoon
Ji Yun Noh
Hee Jin Cheong
Woo Joo Kim
Sun Kyung Yoon
Se-Jin Park
WonSeok Gwak

Frontiers in Immunology

doi 10.3389/fimmu.2024.1385135

Original Research

Accepted on 22 Apr 2024

The Single-Dose Janssen Ad26.COV2.S COVID-19 Vaccine Elicited Robust and Persistent Anti-Spike IgG Antibody Responses in A 12-Month Ugandan Cohort

in Vaccines and Molecular Therapeutics

Jennifer Serwanga
LABAN KATO
GERALD KEVIN OLUKA
Violet Ankunda
Jackson Sembera
Claire Baine
Isaac Kitabye
Angela Namuyanja
Solomon Opio
Joseph Ssebwana Katende

Frontiers in Immunology

doi 10.3389/fimmu.2024.1384668

Original Research

Accepted on 22 Apr 2024

Immunoinformatics Assisted Profiling of West Nile Virus Proteome to Determine Immunodominant Epitopes for the Development of Next-Generation Multi-Peptide Vaccine

in Vaccines and Molecular Therapeutics

Alaa Karkashan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1395870

Original Research

Published on 22 Apr 2024

Lipid nanoparticle composition for adjuvant formulation modulates disease after influenza virus infection in quadrivalent influenza vaccine vaccinated mice

in Vaccines and Molecular Therapeutics

Sonia Jangra
Alexander Lamoot
Gagandeep Singh
Gabriel Laghlali
Yong Chen
Tingting Ye
Adolfo García-Sastre
Bruno G. De Geest
Michael Schotsaert

Frontiers in Immunology

doi 10.3389/fimmu.2024.1370564

350 views

Original Research

Accepted on 19 Apr 2024

A TLR4 ligand-based adjuvant for promoting the immunogenicity of Typhoid subunit vaccines

in Vaccines and Molecular Therapeutics

Kishore R Alugupalli

Frontiers in Immunology

doi 10.3389/fimmu.2024.1383476

Original Research

Accepted on 19 Apr 2024

Heterologous Ad26/Ad5 adenovirus-vectored vaccines elicited SARS-CoV-2-specific antibody responses with potent Fc activities

in Vaccines and Molecular Therapeutics

Jéromine Klingler
Shreyas Kowdle
Juan Bandres
Rozita Emami-Gorizi
Raymond A Alvarez
Fatima Amanat
Charles Gleason
Giulio Kleiner
Viviana Simon
Alexis Edelstein

Frontiers in Immunology

doi 10.3389/fimmu.2024.1382619

Editorial

Published on 18 Apr 2024

Editorial: Precision vaccinology for infectious diseases

in Vaccines and Molecular Therapeutics

Mahbuba Rahman
Mehdi Adeli
Herb E. Schellhorn
Puthen Veettil Jithesh
Ofer Levy

Frontiers in Immunology

doi 10.3389/fimmu.2024.1400443

225 views

Original Research

Published on 18 Apr 2024

Rapid generation of human recombinant monoclonal antibodies from antibody-secreting cells using ferrofluid-based technology

in Vaccines and Molecular Therapeutics

Veronica Strazza
Marco Rossi
Andrea Avati
Giusy Tiseo
Marco Falcone
Maria Grazia Cusi
Francesco Menichetti
Paola Ricciardi-Castagnoli
Cristina Tinti
Piero Pileri

Frontiers in Immunology

doi 10.3389/fimmu.2024.1341389

328 views

Navigation group

Articles

Effectiveness of Different Booster Vaccine Combinations Against SARS-CoV-2 During a Six-Month Follow-Up in Mexico and Argentina

Tissue-specific sex differences in pediatric and adult immune cell composition and function

Sex Differences in Immune Protection in Mice Conferred by Heterologous Vaccines for Pneumonic Plague

Vaccine hesitancy in patients presenting to a specialized allergy center: clinical relevant sensitizations, impact on mental health and vaccination rates

Low-dose M.tb infection but not BCG or MTBVAC vaccination enhances heterologous antibody titers in non-human primates

A conserved motif in the immune-subdominant RAP-1 related antigen of Babesia bovis contains a B-cell epitope recognized by antibodies from protected cattle

Refined analytical pipeline for the pharmacodynamic assessment of T-cell responses to vaccine antigens

Maintenance of homeostasis by TLR4 ligands

Long-term humoral and cellular immunity against vaccine strains and Omicron subvariants (BQ.1.1, BN.1, XBB.1, and EG.5) after bivalent COVID-19 vaccination

The Single-Dose Janssen Ad26.COV2.S COVID-19 Vaccine Elicited Robust and Persistent Anti-Spike IgG Antibody Responses in A 12-Month Ugandan Cohort

Immunoinformatics Assisted Profiling of West Nile Virus Proteome to Determine Immunodominant Epitopes for the Development of Next-Generation Multi-Peptide Vaccine

Lipid nanoparticle composition for adjuvant formulation modulates disease after influenza virus infection in quadrivalent influenza vaccine vaccinated mice

A TLR4 ligand-based adjuvant for promoting the immunogenicity of Typhoid subunit vaccines

Heterologous Ad26/Ad5 adenovirus-vectored vaccines elicited SARS-CoV-2-specific antibody responses with potent Fc activities

Editorial: Precision vaccinology for infectious diseases

Rapid generation of human recombinant monoclonal antibodies from antibody-secreting cells using ferrofluid-based technology